SureSwab® Advanced Candida Vaginitis (CV), TMA

This is an in vitro nucleic acid amplification test for the detection of RNA from microorganisms associated with vulvovaginal candidiasis. The assay utilizes transcription-mediated amplification (TMA) to detect and qualitatively report results for the following organisms: Candida species group (C albicans, C tropicalis, C parapsilosis, C dubliniensis) and Candida glabrata.¹

Unlike the SureSwab, Candidiasis, PCR test, the SureSwab Advanced Candida Vaginitis (CV), TMA test will not report the individual Candida species detected (C albicans, C tropicalis, C parapsilosis, C dubliniensis). In addition, SureSwab Advanced Candida Vaginitis (CV), TMA uses a Food and Drug Administration (FDA)-cleared test, whereas the SureSwab, Candidiasis, PCR is a laboratory-developed test.

This assay also allows for the self-collection of vaginal specimens by patients in a clinical setting.